Ramipril
"Ramipril" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.
| Descriptor ID |
D017257
|
| MeSH Number(s) |
D03.605.084.750
|
| Concept/Terms |
Vesdil- Vesdil
- Promed Brand of Ramipril
- AstraZeneca Brand of Ramipril
Triatec- Triatec
- Altace
- Astra Brand of Ramipril
- Aventis Brand of Ramipril
- Zabien
- Delix
- Hoechst Brand of Ramipril
- Monarch Brand of Ramipril
- Ramace
- Tritace
- Acovil
- Aventis Pharma Brand of Ramipril
Carasel- Carasel
- Almirall Brand of Ramipril
|
Below are MeSH descriptors whose meaning is more general than "Ramipril".
Below are MeSH descriptors whose meaning is more specific than "Ramipril".
This graph shows the total number of publications written about "Ramipril" by people in this website by year, and whether "Ramipril" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ramipril" by people in Profiles.
-
Tallam LS, Jandhyala BS. Significance of exaggerated natriuresis after angiotensin AT1 receptor blockade or angiotensin- converting enzyme inhibition in obese Zucker rats. Clin Exp Pharmacol Physiol. 2001 May-Jun; 28(5-6):433-40.
-
Sakamoto T, Chen C, Lokhandwala MF. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul; 350(1):84-9.